Cargando…
A safety study of high concentration and high frequency intravitreal injection of conbercept in rabbits
The novel anti-VEGF drug conbercept has been used in the treatment of several retinal neovascular diseases. Owning to the alteration of the structure, the newest drug is capable of combining more molecular targets and present higher affinity to the angiogenesis promoting factors. However, it is unkn...
Autores principales: | Wang, Jiaming, Lei, Chunyan, Tao, Lifei, Wu, Quan, Ke, Xiao, Qiu, Yiguo, Lei, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428866/ https://www.ncbi.nlm.nih.gov/pubmed/28377591 http://dx.doi.org/10.1038/s41598-017-00683-x |
Ejemplares similares
-
Intraocular Pharmacokinetics and Safety of Subretinal Injection Compared with Intravitreal Application of Conbercept in Vitrectomized Rabbit Eyes
por: Yao, Teng-teng, et al.
Publicado: (2020) -
Concentrations of VEGF and PlGF Decrease in Eyes After Intravitreal Conbercept Injection
por: Zhou, Jun, et al.
Publicado: (2018) -
EFFICACY AND SAFETY OF INTRAVITREAL CONBERCEPT INJECTIONS IN MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION
por: Sun, Zuhua, et al.
Publicado: (2017) -
A Study on the Drug Concentration in Fellow Eyes After Unilateral Intravitreal Injection of Conbercept Into New Zealand Rabbit Eyes
por: Di, Yu, et al.
Publicado: (2021) -
Observation of total VEGF level in hyperglycemic mouse eyes after intravitreal injection of the novel anti-VEGF drug conbercept
por: Du, Liping, et al.
Publicado: (2015)